Triple Hair Group announces arrangement with Pharmacy Solutions

  • The arrangement includes a licensing agreement for Triple Hair’s patented products in the US
  • Pharmacy Solutions specializes in over-the-counter and prescription hair loss medications, offering unparalleled customized compounding solutions for over 30 years
  • Pharmacy Solutions is licensed in 47 states and has pending licenses in the remaining 3 states

MONTREAL, June 21, 2022 (GLOBE NEWSWIRE) — Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to announce that it has entered into a strategic licensing agreement with Pharmacy Solutions to compound Triple Hair’s hair growth products in the United States. Alopecia is an under-served global market of USD 7.8 billion in 2021, estimated to reach USD 14.2 billion in 2028.

“This is truly game-changing for Triple Hair, to have Pharmacy Solutions as a strategic partner for the development and sales of our hair growth products in the US,” said Jean-Philippe Gravel, President and CEO of Triple Hair. “This agreement has multiple benefits. It allows us to offer our patented triple combination hair growth product and our two over-the-counter brands, RIZN and Plenty Natural, available to hair loss sufferers across the US. Pharmacy Solutions is a leader in compounding and delivery of pharmaceutical products.”

“We are very pleased to partner with Triple Hair, whose hair growth products fit perfectly with our business model and expertise,” said Kim Siegenthaler, Director of Business Development at Pharmacy Solutions. “They help fill a critical need and address a very large potential market. We are excited to enter into this partnership with Triple Hair and the opportunity to offer its products within the US.”

The patented triple combination hair growth product is the first product of its kind to combine 3 proven ingredients for the treatment of androgenic alopecia on the market.